Tag: Lemtrada

EMA Has Started a Review of The Multiple Sclerosis Medicine Lemtrada

EMA has started a review of the multiple sclerosis medicine Lemtrada (alemtuzumab) following new reports of immune-mediated conditions (caused by the body’s defence system not working properly) and pr...